Variant B.1.617.1 (Kappa ) Peptide Pool SARS-CoV-2 (Spike Glycoprotein)

This peptide pool with 25 peptides covers all mutations in the Spike Glycoprotein derived from the kappa variant B.1.617.1 of SARS-CoV-2 which emerged in India in October 2020. Data from the RKI (Germany): India, Oct. 2020: G142D, E154K, L452R, E484Q, D614G, P681R, Q1071H.

Possible applications: T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response.

Each peptide purified by solid phase extraction and purity checked by ESI-MS.

Peptide sequences included (each with 25µg):
KVCEFQFCNDPFLDV NGVQGFNCYFPLQSY PAHEKNFTTAPAICH FQFCNDPFLDVYYHK GTNTSNQVAVLYQGV NDPFLDVYYHKNNKS SNQVAVLYQGVNCTE LDVYYHKNNKSWMKS AVLYQGVNCTEVPVA YHKNNKSWMKSEFRV QGVNCTEVPVAIHAD NKSWMKSEFRVYSSA GICASYQTQTNSRRR MKSEFRVYSSANNCT SYQTQTNSRRRARSV LDSKVGGNYNYRYRL QTNSRRRARSVASQS VGGNYNYRYRLFRKS RRRARSVASQSIIAY YNYRYRLFRKSNLKP PHGVVFLHVTYVPAH YQAGSTPCNGVQGFN VFLHVTYVPAHEKNF STPCNGVQGFNCYFP VTYVPAHEKNFTTAP

Dissolve in a minimum amount of pure DMSO (approx. 40µL) and dilute with water to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system.

Protein ID: P0DTC2 (swiss prot)